Patent details

EP3765024 Title: NOVEL PHARMACEUTICAL FORMULATION COMPRISING DUAL NK-1/NK-3 RECEPTOR ANTAGONISTS.

Basic Information

Publication number:
EP3765024
PCT Application Number:
EP2019056303
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197118664
PCT Publication Number:
WO2019175253
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL PHARMACEUTICAL FORMULATION COMPRISING DUAL NK-1/NK-3 RECEPTOR ANTAGONISTS.
French Title of Invention:
NOUVELLE FORMULATION PHARMACEUTIQUE COMPRENANT DEUX ANTAGONISTES RECEPTEURS DE NK-1/NK-3.
German Title of Invention:
NEUE PHARMAZEUTISCHE FORMULIERUNG MIT DUALEN NK-1/NK-3-REZEPTOR-ANTAGONISTEN.
SPC Number:

Dates

Filing date:
13/03/2019
Grant date:
22/11/2023
EP Publication Date:
20/01/2021
PCT Publication Date:
19/09/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/11/2023
EP B1 Publication Date:
22/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/03/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/11/2023
 
 

Name:
KaNDy Therapeutics Limited
Address:
400 South Oak Way, Reading, Berkshire RG2 6AD, United Kingdom (GB)

Agent

Name:
ARONOVA S.A.
From:
07/02/2024
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
ELDER, David
Address:
United Kingdom (GB)

2

Name:
TROWER, Mike
Address:
United Kingdom (GB)

3

Name:
KERR, Mary
Address:
United Kingdom (GB)

4

Name:
BUSH, Derek
Address:
United States (US)

5

Name:
LAZARO, Monica
Address:
United States (US)

Priority

Priority Number:
201862642622 P
Priority Date:
14/03/2018
Priority Country:
United States (US)

Classification

IPC classification:
C07D 498/04; A61P 5/24; A61K 31/5383; A61K 9/08; A61K 9/48; A61K 47/14; A61P 25/00;

Publication

European Patent Bulletin

1

Issue number:
202347
Publication date:
22/11/2023
Description:
Grant (B1)

2

Issue number:
202437
Publication date:
11/09/2024
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/02/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
07/02/2024 Power Of Attorney 1
09/02/2024 Outgoing Correspondence 1